Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Peripheral Vasculitis, Intermediate Uveitis and Interferon Use in Multiple Sclerosis.
Peptidyl Arginine Deiminases and Neurodegenerative Diseases.
Peripheral sphingolipids are associated with variation in white matter microstructure in older adults.
Coding in Multiple Sclerosis and Other Demyelinating Diseases.
The role of the wnt canonical signaling in neurodegenerative diseases.
Lymphocryptovirus Infection of Nonhuman Primate B Cells Converts Destructive into Productive Processing of the Pathogenic CD8 T Cell Epitope in Myelin Oligodendrocyte Glycoprotein.
Multiple sclerosis: clinical profiling and data collection as prerequisite for personalized medicine approach.
STARs in the CNS.
Testing the health promotion model for adherence and quality of life in individuals with multiple sclerosis.
Subcutaneous vs. Intravenous Immunoglobulin for Chronic Autoimmune Neuropathies: A Meta-analysis.
Peripheral and Central Neuroinflammatory Changes and Pain Behaviors in an Animal Model of Multiple Sclerosis.
Muscular, cardiac, ventilatory and metabolic dysfunction in patients with multiple sclerosis: Implications for screening, clinical care and endurance and resistance exercise therapy, a scoping review.
Ex vivo expanded regulatory T cells CD4(+)CD25(+)FoxP3(+)CD127(Low) develop strong immunosuppressive activity in patients with remitting-relapsing multiple sclerosis.
Structural sex differences at disease onset in multiple sclerosis patients.
Diagnosis of CCSVI in Meniere syndrome.
Role of Therapeutic Plasma Exchange in Treatment of Tumefactive Multiple Sclerosis-Associated Low CD4 and CD8 Levels.
Analysis of the Relationship between the Month of Birth and Risk of Multiple Sclerosis in a Spanish Population.
Identification of Tricyclic Agonists of Sphingosine-1-Phosphate Receptor 1 (S1P1) Employing Ligand-Based Drug Design.
A Novel Function of TBK1 as a Target of Cdon in Oligodendrocyte Differentiation and Myelination.
Maternal Inflammation Disrupts Fetal Neurodevelopment via Increased Placental Output of Serotonin to the Fetal Brain.
The immunomodulator decoy receptor 3 improves locomotor functional recovery after spinal cord injury.
Co-transplantation of MRF-overexpressing oligodendrocyte precursor cells and Schwann cells promotes recovery in rat after spinal cord injury.
Multiple sclerosis: Molecular mimicry of an antimyelin HLA class I restricted T-cell receptor.
Brain Atrophy as a Measure of Neuroprotective Drug Effects in Multiple Sclerosis: Influence of Inflammation.
Switching or Discontinuing Disease-Modifying Therapies for Multiple Sclerosis.
Pages
« first
‹ previous
…
781
782
783
784
785
786
787
788
789
…
next ›
last »